Filter News
Area of Research
- (-) Biology and Environment (20)
- (-) Neutron Science (14)
- Clean Energy (82)
- Computational Biology (1)
- Computer Science (2)
- Electricity and Smart Grid (1)
- Energy Sciences (1)
- Functional Materials for Energy (2)
- Fusion and Fission (4)
- Isotopes (1)
- Materials (38)
- Materials for Computing (7)
- National Security (4)
- Nuclear Science and Technology (1)
- Supercomputing (22)
News Topics
- (-) Coronavirus (18)
- (-) Energy Storage (13)
- 3-D Printing/Advanced Manufacturing (15)
- Advanced Reactors (2)
- Artificial Intelligence (14)
- Big Data (10)
- Bioenergy (50)
- Biology (75)
- Biomedical (26)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (13)
- Clean Water (13)
- Climate Change (41)
- Composites (5)
- Computer Science (31)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (21)
- Environment (97)
- Exascale Computing (4)
- Fossil Energy (1)
- Frontier (4)
- Fusion (1)
- Grid (3)
- High-Performance Computing (22)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (10)
- Materials (25)
- Materials Science (28)
- Mathematics (3)
- Mercury (7)
- Microscopy (13)
- Molten Salt (1)
- Nanotechnology (17)
- National Security (5)
- Net Zero (2)
- Neutron Science (99)
- Nuclear Energy (4)
- Partnerships (5)
- Physics (11)
- Polymers (3)
- Quantum Computing (1)
- Quantum Science (7)
- Renewable Energy (1)
- Security (4)
- Simulation (14)
- Space Exploration (3)
- Summit (15)
- Sustainable Energy (32)
- Transformational Challenge Reactor (1)
- Transportation (8)
Media Contacts
NellOne Therapeutics has licensed a drug delivery system from the Department of Energy’s Oak Ridge National Laboratory that is designed to transport therapeutics directly to cells infected by SARS-CoV-2, the virus causing COVID-19.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team led by Dan Jacobson of Oak Ridge National Laboratory used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
With the rise of the global pandemic, Omar Demerdash, a Liane B. Russell Distinguished Staff Fellow at ORNL since 2018, has become laser-focused on potential avenues to COVID-19 therapies.
In the race to identify solutions to the COVID-19 pandemic, researchers at the Department of Energy’s Oak Ridge National Laboratory are joining the fight by applying expertise in computational science, advanced manufacturing, data science and neutron science.
Researchers at the Department of Energy’s Oak Ridge National Laboratory have used Summit, the world’s most powerful and smartest supercomputer, to identify 77 small-molecule drug compounds that might warrant further study in the fight
Two of the researchers who share the Nobel Prize in Chemistry announced Wednesday—John B. Goodenough of the University of Texas at Austin and M. Stanley Whittingham of Binghamton University in New York—have research ties to ORNL.
Ionic conduction involves the movement of ions from one location to another inside a material. The ions travel through point defects, which are irregularities in the otherwise consistent arrangement of atoms known as the crystal lattice. This sometimes sluggish process can limit the performance and efficiency of fuel cells, batteries, and other energy storage technologies.